The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial
Open accessAbstract
Objectives: The aim of the study was to evaluate the effects of infant formula supplemented with 2 human milk oligosaccharides (HMOs) on infant growth, tolerance, and morbidity. Methods: Healthy infants, 0 to 14 days old, were randomized to an intact‐protein, cow's milk–based infant formula (control, n = 87) or the same formula with 1.0 g/L 2′fucosyllactose (2′FL) and 0.5 g/L lacto‐N‐neotetraose (LNnT) (test, n = 88) from enrollment to 6 months; all infants received standard follow‐up formula without HMOs from 6 to 12 months. Primary endpoint was weight gain through 4 months. Secondary endpoints included additional anthropometric measures, gastrointestinal tolerance, behavioral patterns, and morbidity through age 12 months. Results: Weight gain was similar in both groups (mean difference [95% confidence interval] test vs control: −0.30 [−1.94, 1.34] g/day; lower bound of 95% confidence interval was above noninferiority margin [−3 g/day]). Digestive symptoms and behavioral patterns were similar between groups; exceptions included softer stool (P = 0.021) and fewer nighttime wake‐ups (P = 0.036) in the test group at 2 months. Infants receiving test (vs control) had significantly fewer parental reports (P = 0.004–0.047) of bronchitis through 4 (2.3% vs 12.6%), 6 (6.8% vs 21.8%), and 12 months (10.2% vs 27.6%); lower respiratory tract infection (adverse event cluster) through 12 months (19.3% vs 34.5%); antipyretics use through 4 months (15.9% vs 29.9%); and antibiotics use through 6 (34.1% vs 49.4%) and 12 months (42.0% vs 60.9%). Conclusions: Infant formula with 2′FL and LNnT is safe, well‐tolerated, and supports age‐appropriate growth. Secondary outcome findings showing associations between consuming HMO‐supplemented formula and lower parent‐reported morbidity (particularly bronchitis) and medication use (antipyretics and antibiotics) warrant confirmation in future studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Onís, M., Onyango, A. W., Borghi, E., Siyam, A., Pinol, A., Garza, C., Martines, J., Martorell, R., Victora, C. G., Bhan, M. K., et al. (2006) · (2006) · Cited by 3,401
Jakobsson, H. E., Abrahamsson, T. R., Jenmalm, M. C., Harris, K., Quince, C., Jernberg, C., Björkstén, B., Engstrand, L., & Andersson, A. F. (2014) · Gut · doi:10.1136/gutjnl-2012-303249 · Cited by 1,011
Human milk glycobiome and its impact on the infant gastrointestinal microbiota
Zivkovic, A. M., German, J. B., Lebrilla, C. B., & Mills, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000083107 · Cited by 679
Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways
Marcobal, A., Barboza, M., Sonnenburg, E. D., Pudlo, N., Martens, E. C., Desai, P., Lebrilla, C. B., Weimer, B. C., Mills, D. A., German, J. B., et al. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.007 · Cited by 574
Mode of delivery affects the bacterial community in the newborn gut
Biasucci, G., Rubini, M., Riboni, S., Morelli, L., Bessi, E., & Retetangos, C. (2010) · Early Human Development · doi:10.1016/j.earlhumdev.2010.01.004 · Cited by 507
The functional biology of human milk oligosaccharides
Bode, L. (2015) · Early Human Development · doi:10.1016/j.earlhumdev.2015.09.001 · Cited by 482
Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants
Morrow, A. L., Ruiz-Palacios, G. M., Altaye, M., Jiang, X., Lourdes Guerrero, M., Meinzen-Derr, J. K., Farkas, T., Chaturvedi, P., Pickering, L. K., & Newburg, D. S. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.04.054 · Cited by 464
Physiology of Consumption of Human Milk Oligosaccharides by Infant Gut-associated Bifidobacteria
Asakuma, S., Hatakeyama, E., Urashima, T., Yoshida, E., Katayama, T., Yamamoto, K., Kumagai, H., Ashida, H., Hirose, J., & Kitaoka, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248138 · Cited by 442
Variation of human milk oligosaccharides in relation to milk groups and lactational periods
Thurl, S., Munzert, M., Henker, J., Boehm, G., Müller-Werner, B., Jelinek, J., & Stahl, B. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510002072 · Cited by 438
Lewis, Z. T., Totten, S. M., Smilowitz, J. T., Popovic, M., Parker, E., Lemay, D. G., Van Tassell, M. L., Miller, M. J., Jin, Y.-S., German, J. B., et al. (2015) · Microbiome · doi:10.1186/s40168-015-0071-z · Cited by 412
Cited by
Systematic review of the concentrations of oligosaccharides in human milk
Thurl, S., Munzert, M., Boehm, G., Matthews, C., & Stahl, B. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux044 · Cited by 406
Production of HMOs using microbial hosts — from cell engineering to large scale production
Bych, K., Mikš, M. H., Johanson, T., Hederos, M. J., Vigsnæs, L. K., & Becker, P. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.11.003 · Cited by 263
Nutrients and Microbiota in Lung Diseases of Prematurity: The Placenta-Gut-Lung Triangle
Piersigilli, F., Van Grambezen, B., Hocq, C., & Danhaive, O. (2020) · Nutrients · doi:10.3390/nu12020469 · Cited by 64
The human microbiome in clinical translation: from bench to bedside
Bautista, J., Echeverría, C. E., Maldonado-Noboa, I., Ojeda-Mosquera, S., Hidalgo-Tinoco, C., & López-Cortés, A. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1632435 · Cited by 55
Metadata
- Authors
- Puccio, G., Alliet, P., Cajozzo, C., Janssens, E., Corsello, G., Sprenger, N., Wernimont, S., Egli, D., Gosoniu, L., & Steenhout, P.
- Venue
- Journal of Pediatric Gastroenterology and Nutrition
- Publisher
- Wiley
- Published
- 2017-04
- Volume
- 64
- Issue
- 4
- Pages
- 624-631
- ISSN
- 0277-2116 (ISSN-L)
- 1536-4801
- OpenAlex
- W2579028914
- Cited by
- 349
- References
- 45
- FWCI
- 20.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial. https://app.cochat.ai/papers/10.1097/mpg.0000000000001520
- The paper
- Puccio, G., Alliet, P., Cajozzo, C., Janssens, E., Corsello, G., Sprenger, N., Wernimont, S., Egli, D., Gosoniu, L., & Steenhout, P. (2017). Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1097/mpg.0000000000001520
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.